Literature DB >> 16888797

MRI detects myocardial iron in the human heart.

Nilesh R Ghugre1, Cathleen M Enriquez, Ignacio Gonzalez, Marvin D Nelson, Thomas D Coates, John C Wood.   

Abstract

Iron-induced cardiac dysfunction is a leading cause of death in transfusion-dependent anemia. MRI relaxation rates R2(1/T2) and R2*(1/T2*) accurately predict liver iron concentration, but their ability to predict cardiac iron has been challenged by some investigators. Studies in animal models support similar R2 and R2* behavior with heart and liver iron, but human studies are lacking. To determine the relationship between MRI relaxivities and cardiac iron, regional variations in R2 and R2* were compared with iron distribution in one freshly deceased, unfixed, iron-loaded heart. R2 and R2* were proportionally related to regional iron concentrations and highly concordant with one another within the interventricular septum. A comparison of postmortem and in vitro measurements supports the notion that cardiac R2* should be assessed in the septum rather than the whole heart. These data, along with measurements from controls, provide bounds on MRI-iron calibration curves in human heart and further support the clinical use of cardiac MRI in iron-overload syndromes. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888797      PMCID: PMC2887674          DOI: 10.1002/mrm.20981

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  20 in total

1.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

2.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

Authors:  G M Brittenham; D G Nathan; N F Olivieri; M J Pippard; D J Weatherall
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

3.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

Authors:  T G St Pierre
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

4.  Deferiprone versus desferrioxamine in thalassaemia, and T2* validation and utility.

Authors:  Roland Fischer; Rainer Engelhardt
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

5.  Improved R2* measurements in myocardial iron overload.

Authors:  Nilesh R Ghugre; Cathleen M Enriquez; Thomas D Coates; Marvin D Nelson; John C Wood
Journal:  J Magn Reson Imaging       Date:  2006-01       Impact factor: 4.813

6.  Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.

Authors:  Lisa J Anderson; Beatrix Wonke; Emma Prescott; Sally Holden; J Malcolm Walker; Dudley J Pennell
Journal:  Lancet       Date:  2002-08-17       Impact factor: 79.321

7.  Iron in the heart. Etiology and clinical significance.

Authors:  L M Buja; W C Roberts
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

8.  Proton transverse relaxation rate (R2) images of liver tissue; mapping local tissue iron concentrations with MRI [corrected].

Authors:  Paul R Clark; Wanida Chua-Anusorn; Timothy G St Pierre
Journal:  Magn Reson Med       Date:  2003-03       Impact factor: 4.668

9.  Multi-element analysis of trace element levels in human autopsy tissues by using inductively coupled atomic emission spectrometry technique (ICP-AES).

Authors:  Reem Rahil-Khazen; Bjørn J Bolann; Andreas Myking; Rune J Ulvik
Journal:  J Trace Elem Med Biol       Date:  2002       Impact factor: 3.849

10.  Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium.

Authors:  D H Fitchett; D J Coltart; W A Littler; M J Leyland; T Trueman; D I Gozzard; T J Peters
Journal:  Cardiovasc Res       Date:  1980-12       Impact factor: 10.787

View more
  51 in total

1.  Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Authors:  Vineeta Ojha; Kartik P Ganga; Tulika Seth; Ambuj Roy; Nitish Naik; Priya Jagia; Gurpreet S Gulati; Sanjeev Kumar; Sanjiv Sharma
Journal:  Eur Radiol       Date:  2021-03-15       Impact factor: 5.315

2.  Diagnosis and management of transfusion iron overload: the role of imaging.

Authors:  John C Wood
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

Review 3.  Magnetic resonance imaging measurement of iron overload.

Authors:  John C Wood
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

Review 4.  Use of magnetic resonance imaging to monitor iron overload.

Authors:  John C Wood
Journal:  Hematol Oncol Clin North Am       Date:  2014-08       Impact factor: 3.722

5.  Cardiac R2* values are independent of the image analysis approach employed.

Authors:  Antonella Meloni; Hugh Young Rienhoff; Amber Jones; Alessia Pepe; Massimo Lombardi; John C Wood
Journal:  Magn Reson Med       Date:  2013-10-01       Impact factor: 4.668

6.  Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron.

Authors:  Antonella Meloni; Jon Detterich; Vasili Berdoukas; Alessia Pepe; Massimo Lombardi; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2013-02-06       Impact factor: 10.047

Review 7.  Estimating tissue iron burden: current status and future prospects.

Authors:  John C Wood
Journal:  Br J Haematol       Date:  2015-03-12       Impact factor: 6.998

8.  Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification.

Authors:  Taigang He; Peter D Gatehouse; Gillian C Smith; Raad H Mohiaddin; Dudley J Pennell; David N Firmin
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

9.  Practical implications of liver and heart iron load assessment by T2*-MRI in children and adults with transfusion-dependent anemias.

Authors:  Sarah Deborah Chirnomas; Marnix Geukes-Foppen; Kristen Barry; Jennifer Braunstein; Leslie A Kalish; Ellis J Neufeld; Andrew J Powell
Journal:  Am J Hematol       Date:  2008-10       Impact factor: 10.047

Review 10.  Cardiac iron across different transfusion-dependent diseases.

Authors:  John C Wood
Journal:  Blood Rev       Date:  2008-12       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.